Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
226.1 USD | -1.75% | -3.16% | -4.36% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.36% | 11.82B | |
+17.93% | 47.02B | |
+48.77% | 41.86B | |
+0.80% | 41.76B | |
-4.27% | 28.8B | |
+12.12% | 26.05B | |
-21.25% | 19.15B | |
+4.32% | 12.55B | |
+28.51% | 12.34B | |
+20.31% | 11.8B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Deutsche Bank Raises Charles River Laboratories International Price Target to $275 From $245, Maintains Buy Rating